XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net loss $ (3,467) $ (5,983)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 2,499 2,825
Amortization of operating lease right-of-use assets 174 168
Amortization of deferred financing costs and debt discount 70 83
Change in allowance for credit losses 30 (138)
Stock-based compensation expense 275 677
Loss on disposal of property and equipment 19 24
Inventory write-off 141 0
Loss on debt extinguishment 0 909
Changes in operating assets and liabilities:    
Accounts receivable 431 208
Inventories 6 886
Prepaid expenses and other assets (119) 190
Accounts payable (466) 351
Accrued expenses and other liabilities 290 211
Deferred revenues 74 (95)
Operating lease liabilities (170) (186)
Net cash (used in) provided by operating activities (213) 130
Cash flows from investing activities:    
Purchase of property and equipment (1,070) (3,495)
Net cash used in investing activities (1,070) (3,495)
Cash flows from financing activities:    
Payment of contingent consideration (18) 0
Proceeds from long-term debt 0 7,000
Payment of deferred financing costs 0 (35)
Net cash (used in) provided by financing activities (18) 6,965
Net (decrease) increase in cash, cash equivalents and restricted cash (1,301) 3,600
Cash, cash equivalents and restricted cash at beginning of period 8,118 6,795
Cash, cash equivalents and restricted cash at end of period 6,817 10,395
Cash and cash equivalents 5,483 9,034
Restricted cash 1,334 1,361
Supplemental disclosure of cash flow information:    
Cash paid during the year for interest 990 497
Supplemental schedule of non-cash operating, investing and financing activities:    
Operating lease right-of-use assets obtained in exchange for operating lease liabilities 977 0
Transfer of property and equipment to inventories 166 102
Accrued payment of contingent consideration 9 42
Modification of common stock warrants 0 384
Accrued exit fee recorded as debt discount 0 450
Deferred financing costs in accounts payable $ 0 $ 62